RetiSpec

Medical Devices & EquipmentSeries AToronto, Canadaretispec.com

Latest round

Series A

Last raised

Jul 2024

Total raised

$10M

Investors

7

About RetiSpec

Founded in 2016 by Eliav Shaked (CEO) and Roy Kirshon (COO), and based in Toronto, Canada, RetiSpec Inc. operates as a research medical imaging company that develops tools for the early detection of biomarkers of Alzheimer's disease in the eye. In July 2024, RetiSpec Inc. The company employs AI-driven retinal imaging that uses data-rich retinal images captured with existing retinal imaging cameras to provide early and accurate diagnosis of neurodegenerative disease markers using eye examinations. RetiSpec's non-invasive, AI-based solution provides detailed analysis for using hyperspectral imaging to detect Alzheimer's disease.

Who invested in RetiSpec

7 investors across 1 round

See all investors in RetiSpec

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jul 21, 2024

    Amount

    $10M

    Investors

    Locked

Questions about RetiSpec

Who invested in RetiSpec?

RetiSpec has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has RetiSpec raised?

RetiSpec has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did RetiSpec last raise money?

RetiSpec's most recent round on record is a Series A, in Jul 2024.

What does RetiSpec do?

Founded in 2016 by Eliav Shaked (CEO) and Roy Kirshon (COO), and based in Toronto, Canada, RetiSpec Inc.

Where is RetiSpec headquartered?

RetiSpec is headquartered in Toronto, Canada.

Which VCs invest in companies like RetiSpec?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at RetiSpec's stage. Their profiles are linked below.

Raising like RetiSpec? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.